Alternative strategies for stroke care - Cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial

被引:75
|
作者
Patel, A
Knapp, M
Perez, I
Evans, A
Kalra, L
机构
[1] Inst Psychiat, David Goldberg Ctr, Hlth Serv Res Dept, Ctr Econ Mental Hlth, London SE5 8AF, England
[2] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England
[3] Guys Kings & St Thomas Sch Med, Dept Med, London, England
关键词
costs and cost analysis; randomized controlled trials; rehabilitation; stroke management;
D O I
10.1161/01.STR.0000105390.20430.9F
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Although stroke units reduce mortality and institutionalization, their comparative cost-effectiveness is unknown. Methods-Healthcare, social services, and informal care costs were compared for 447 acute stroke patients randomly assigned to stroke unit, stroke team, or domiciliary stroke care. Prospective and retrospective methods were used to identify resource use over 12 months after stroke onset. Cost-effectiveness and cost-utility analyses were undertaken. Results-Mean healthcare and social care costs over 12 months were pound11450 for stroke unit, pound9527 for stroke team, and pound6840 for domiciliary care. More than half the costs were for the initial episode of care. Institutionalization was a large proportion of follow-up costs. Inclusion of informal care increased costs considerably. When informal care was excluded, the incremental cost-effectiveness ratio per percentage point in deaths or institutionalizations avoided in the first year was pound496 for the stroke unit over domiciliary care; incremental cost per quality-adjusted life year quality-adjusted life year gained was pound64097 between these 2 groups. The stroke team was dominated by domiciliary care. Conclusions-Cost perspectives, especially those related to long-term and informal care, are important when stroke services are evaluated. Improved health outcomes in the stroke unit come at a higher cost.
引用
收藏
页码:196 / 203
页数:8
相关论文
共 50 条
  • [1] Cost-Effectiveness and Cost-Utility Analyses of Antireflux Medicine
    Gockel, Ines
    Lange, Undine Gabriele
    Schuermann, Olaf
    Jansen-Winkeln, Boris
    Sibbel, Rainer
    Lyros, Orestis
    von dercks, Nikolaus
    [J]. GESUNDHEITSWESEN, 2019, 81 (12) : 1048 - 1056
  • [2] The Adoption of Cost-Effectiveness Acceptability Curves in Cost-Utility Analyses
    Meckley, Lisa M.
    Greenberg, Dan
    Cohen, Joshua T.
    Neumann, Peter J.
    [J]. MEDICAL DECISION MAKING, 2010, 30 (03) : 314 - 319
  • [3] Cost-Effectiveness and Cost-Utility of Internet-Delivered Exposure Therapy for Fibromyalgia: Results From a Randomized, Controlled Trial
    Hedman-Lagerlof, Maria
    Hedman-Lagerlof, Erik
    Ljotsson, Brjann
    Wicksell, Rikard K.
    Flink, Ida
    Andersson, Erik
    [J]. JOURNAL OF PAIN, 2019, 20 (01): : 47 - 59
  • [4] Cost-benefit, cost-effectiveness and cost-utility analyses of periodontitis prevention
    Braegger, U
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2005, 32 : 301 - 313
  • [5] Behavioral activation with mindfulness in treating subthreshold depression in primary care: A cost-utility and cost-effectiveness analysis alongside a randomized controlled trial
    Sun, Yuying
    Wong, Samuel Y. S.
    Zhang, Dexing
    Chen, Cynthia H. J.
    Yip, Benjamin H. K.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 132 : 111 - 115
  • [6] Cost-effectiveness and cost-utility evaluations in radiology
    d'Othée, BJ
    Bettmann, MA
    Pirard, S
    Zhuang, Z
    Black, WC
    [J]. JOURNAL DE RADIOLOGIE, 2001, 82 (12): : 1687 - 1692
  • [7] A Review on Cost-Effectiveness and Cost-Utility of Psychosocial Care in Cancer Patients
    Jansen, Femke
    van Zwieten, Valesca
    Coupe, Veerle M. H.
    Leemans, C. Rene
    Leeuw, Irma M. Verdonck-de
    [J]. ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2016, 3 (02) : 125 - 136
  • [8] The cost-effectiveness of oral health interventions: A systematic review of cost-utility analyses
    Hettiarachchi, Ruvini M.
    Kularatna, Sanjeewa
    Downes, Martin J.
    Byrnes, Joshua
    Kroon, Jeroen
    Lalloo, Ratilal
    Johnson, Newell W.
    Scuffham, Paul A.
    [J]. COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 2018, 46 (02) : 118 - 124
  • [9] What is known about the cost-effectiveness of orphan drugs? Evidence from cost-utility analyses
    Picavet, E.
    Cassiman, D.
    Simoens, S.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (03) : 304 - 307
  • [10] Cost-effectiveness and cost-utility of long-term management strategies for heartburn
    Goeree, R
    O'Brien, BJ
    Blackhouse, G
    Marshall, J
    Briggs, A
    Lad, R
    [J]. VALUE IN HEALTH, 2002, 5 (04) : 312 - 328